Spain – Pharmaceutical products – Suministro por exclusividad de fármaco MARALIXIBAT, Medicamento: LIVMARLI® 9,5 MG/ML s
Gerencia del Área de Salud de Badajoz awarded €552K to Mirum Pharmaceuticals International, B. V. for Construction & Public Works in February 2025 — one of 77 awards this buyer has made, above its typical award size.
Buying agency
Gerencia del Área de Salud de BadajozWinning supplier
Mirum Pharmaceuticals International, B. V.Contract description
Spain – Pharmaceutical products – Suministro por exclusividad de fármaco MARALIXIBAT, Medicamento: LIVMARLI® 9,5 MG/ML sol. oral en el Área de Salud de Badajoz
Related awards · Gerencia del Área de Salud de Badajoz
77 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-176609-2026-2EDWARDS LIFESCIENCES S.L.€4.5M13 Mar 2026 Construction
- ocds-ted-176609-2026-4COM MEDCOR, SL€1.8M13 Mar 2026 Construction
- ocds-ted-176609-2026-3Medtronic Iberica€1.7M13 Mar 2026 Construction
Other wins · Mirum Pharmaceuticals International, B. V.
7 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-524089-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€5.0M11 Aug 2025 Construction
- ocds-ted-824983-2025SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA€4.3M11 Dec 2025 Construction
- ocds-ted-607857-2025Hospital Universitario La Paz€276K17 Sep 2025 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Gerencia del Área de Salud de Badajoz and Mirum Pharmaceuticals International, B. V. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back